"Kabi" Aimeco blood component separator
Taiwan·Risk Class 2·FRESENIUS KABI AG;; Fresenius HemoCare GmbH·Registered Jul 27, 2023 – Jul 27, 2028Active- Analysis ID
- e5da2cdf803d1ce7678f2f1beeef375c
- Customs Code
- DHA05603620506
- Manufacturer
- FRESENIUS KABI AG;; Fresenius HemoCare GmbH
- Manufacturer Country
- Germany
- Authorized Representative
- FRESENIUS KABI TAIWAN LIMITED
- Intended Use
- This product is an automated cytoplasmic separator suitable for collecting blood components, this product can only be used in conjunction with the AmiCORE Apheresis Kit to collect and subtract white blood cell platelets.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9245 Automated hemocytoseparator
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Jul 27, 2023
- Expiry Date
- Jul 27, 2028
Top companies providing products similar to ""Kabi" Aimeco blood component separator"
Recently registered similar products
Access comprehensive regulatory information for "Kabi" Aimeco blood component separator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e5da2cdf803d1ce7678f2f1beeef375c and manufactured by FRESENIUS KABI AG;; Fresenius HemoCare GmbH. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Fresenius Kabi AG;; PLEXUS MANUFACTURING SDN. BHD., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.